Big Gain For Edesa Biotech, Inc.

Edesa Biotech, Inc. (EDSA:NASDAQ) shot up at $7, representing a gain of 36.7%. On Tue, Mar 17, 2026, EDSA:NASDAQ hit a New 2-Week Intraday High of $8.13. The stock appeared on our News Catalysts scanner on Mon, Mar 02, 2026 at 12:36 PM in the 'BIOTECH' category. From Tue, Mar 03, 2026, the stock recorded 30.00% Up Days and 36.36% Green Days

The stock spiked on Mon, Mar 09, 2026 at $8.74 with a volume of 6M+.

About Edesa Biotech, Inc. (EDSA:NASDAQ)

Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.